2016
DOI: 10.1136/bjophthalmol-2015-308272
|View full text |Cite
|
Sign up to set email alerts
|

Safety outcomes and long-term effectiveness of ex vivo autologous cultured limbal epithelial transplantation for limbal stem cell deficiency

Abstract: This study addresses important issues regarding possible risks associated with disarray of the ocular surface homeostasis following autologous CLET in patients with limbal stem cell deficiency, despite the fact that the majority of patients experienced a favourable long-term benefit.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(22 citation statements)
references
References 27 publications
1
21
0
Order By: Relevance
“…A hallmark of effective regeneration of the limbal stem cell function is the maintenance of a transparent and intact corneal epithelium, without central corneal superficial neovascularization, for a period of one year after surgery, which is consistent with a normal homeostasis of the entire human corneal epithelium estimated as ranging from nine to 12 months [7][8][9]. However, weighing the risk-benefit of further surgery after cell therapy for LSCD is a matter of concern, as approximately 50% of successful CLET procedures had shown subsequent corneal surface failure or recurrence of epithelial defects after corrective or reconstructive penetrating keratoplasty (PK) [10][11][12].…”
Section: Introductionsupporting
confidence: 69%
“…A hallmark of effective regeneration of the limbal stem cell function is the maintenance of a transparent and intact corneal epithelium, without central corneal superficial neovascularization, for a period of one year after surgery, which is consistent with a normal homeostasis of the entire human corneal epithelium estimated as ranging from nine to 12 months [7][8][9]. However, weighing the risk-benefit of further surgery after cell therapy for LSCD is a matter of concern, as approximately 50% of successful CLET procedures had shown subsequent corneal surface failure or recurrence of epithelial defects after corrective or reconstructive penetrating keratoplasty (PK) [10][11][12].…”
Section: Introductionsupporting
confidence: 69%
“…34 Following this, several groups have published their outcomes of this technique, however the cultivation protocols are quite variable across groups as summarized in Table 3. [35][36][37][38][39][40][41][42][43][44][45][46][47][48] Broadly there are two techniques of limbal cultivation: a) the suspension culture, where the biopsied limbal tissue is first digested enzymatically to separate the cells from the extracellular matrix and then the cell suspension is placed in culture over a suitable substrate; and b) explant culture where the limbal tissue fragment is sectioned into smaller pieces and placed directly on the substrate without enzymatic digestion. Additionally, the constituents of the culture medium may or may not contain animal-derived products or xenobiotic materials.…”
Section: Cultivated Limbal Epithelial Transplantation (Clet)mentioning
confidence: 99%
“…A recent review article on the safety of CLET reported that since CLET protocols rely on the use of animal material, there is always a potential risk to the patient, and it is possible that the impact of these elements on the outcome of CLET is underestimated 10. The latest clinical study on safety of CLET in 59 eyes with a mean follow-up of 6 years showed that within the first year of surgery 69% of eyes showed one or more adverse events, including 31% that had epithelial healing problems 17. At 1 year only 41% could be considered completely successful using subjective assessment criteria 17…”
Section: Discussionmentioning
confidence: 99%